Published in Biotech Business Week, July 13th, 2009
"Therefore, numerous chemotherapeutic agents should not be administered to patients with liver failure. We retrospectively analysed 14 patients with solid tumours presenting with liver dysfunction induced...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.